PathAIAI-powered pathology platform for precision diagnostics and biomarker discovery.

4.3 (6)

Reviewed by Daniel Nikulshyn·Updated June 2026

Healthcare AI Machine Learning Enterprise Digital Pathology Diagnostics Biotech Drug Discovery

Overview

Our company's mission is to improve patient outcomes with reliable AI-powered technology and meaningful collaboration. We achieve this by providing invaluable insights for biomarker discovery and drug development, and by improving laboratory workflows. At PathAI, we offer an AI-powered pathology platform for precision diagnostics and biomarker discovery. This platform includes a cloud-native, open platform enterprise workflow solution, AISight, which serves as a central hub for case management, image management, and best-in-class artificial intelligence tools. This solution enables multiple histopathology use cases, such as case management, image management, and AI applications. We have a proprietary pathologist contributor network of 450+ board-certified pathologists, who have contributed 32.5 million annotations to aid in the training and validation of our AI-based algorithms. Our technology is used by leading laboratories and research centers to power their digital pathology workflows and AI applications. Our company has partnered with various organizations, including MedStar Health and Labcorp, to deploy our digital pathology platform and advanced AI applications. We have also received FDA clearance for our AISight Dx platform for primary diagnosis. PathAI is a leading company in AI-powered pathology, and we are committed to advancing precision medicine by leveraging the power of artificial intelligence. Our team is passionate about solving big challenges in healthcare and transforming the field of pathology with artificial intelligence.

Key features

AI-assisted tissue and slide analysis
Biomarker detection and quantification
Clinical trial and translational research tools
Digital pathology lab integration
Companion diagnostic development support
Collaboration tools for pathologists

Pricing

Model: Freemium
Category: Decision support
Rating: 4.3 / 5 (6)

Use cases

Accelerate Oncology Biomarker Discovery

Biopharma researchers use PathAI to detect and quantify biomarkers across large tissue sample datasets, speeding up translational research and target identification in oncology programs.

Enrich Clinical Trial Cohorts

Pharma teams leverage AI-assisted slide analysis to identify eligible patients and stratify cohorts based on tissue-level features, improving trial enrichment and outcomes.

Support Routine Clinical Diagnostics

Hospital pathology labs integrate PathAI into digital workflows to assist pathologists in analyzing biopsies with greater consistency and accuracy across cases.

Develop Companion Diagnostics

Diagnostic developers partner with PathAI to build and validate AI-driven companion diagnostics that pair with targeted therapies for precision medicine applications.

Pros & Cons

Pros

Strong focus on clinical-grade accuracy
Used by major pharma and research institutions
Supports biomarker quantification at scale
Integrates with digital pathology workflows

Cons

Targeted at enterprise and lab users, not individuals
Requires digitized slide infrastructure
Limited public pricing transparency

Reviews

4.3

Average from 6 ratings.

Aisha Khan

May 15, 2026

Use it every day

Honestly didn't expect to like it this much. Biomarker detection and quantification is exactly what I needed, and strong focus on clinical-grade accuracy. I do wish requires digitized slide infrastructure, but I reach for it almost every day now and it just clicks.

Fatima Zahra

Mar 26, 2026

Skeptical, then convinced

I went in skeptical — most tools in this space overpromise. It actually delivers on aI-assisted tissue and slide analysis, and strong focus on clinical-grade accuracy caught me off guard. still, I'd recommend giving it a real trial.

Mei-Ling Wong

Dec 24, 2025

Does the job

Pretty happy overall. Biomarker detection and quantification just works and integrates with digital pathology workflows. but no dealbreakers — I'd recommend it to a friend without hesitating.

Joanna Kowalski

Jul 17, 2025

Years in this space

I've evaluated a lot of these over the years. What stands out here is collaboration tools for pathologists — handled better than most — and integrates with digital pathology workflows. Targeted at enterprise and lab users, not individuals is my one real gripe. Worth the time if this is your use case.

Robert Ainsworth

Jun 27, 2025

Compared a few options

Evaluated this against two competitors. Where it wins: biomarker detection and quantification and strong focus on clinical-grade accuracy. Where it lags: requires digitized slide infrastructure. On balance the feature set — especially biomarker detection and quantification — justifies the 4 stars for our use case.

Frank Müller

Jun 14, 2025

Compared a few options

Evaluated this against two competitors. Where it wins: companion diagnostic development support and supports biomarker quantification at scale. Where it lags: targeted at enterprise and lab users, not individuals. On balance the feature set — especially biomarker detection and quantification — justifies the 4 stars for our use case.

Q&A

No questions yet — be the first to ask.

Ask a question

Freemium